Drug intelligence / Profile preview

Nicardipine and Esmolol combination

Development stage
Unknown
Lead developer
Chiesi
Modality
Device-based Delivery → Drug Delivery Systems
Administration
Intravenous
01

Overview

The combination of nicardipine and esmolol is used primarily to manage hemodynamic responses during medical procedures, particularly to blunt blood pressure and heart rate increases during laryngoscopy and tracheal intubation. This combination leverages the complementary mechanisms of these two drugs to provide better blood pressure control than either agent alone. ## Pharmacological Properties Nicardipine is a dihydropyridine calcium channel blocker that primarily affects vascular smooth muscle, causing vasodilation and reducing blood pressure. It works by inhibiting the influx of extracellular calcium across myocardial and vascular smooth muscle cell membranes. Esmolol is a short-acting beta-blocker that reduces heart rate and contractility by blocking beta-adrenergic receptors in the heart. The combination of these two medications provides more effective blood pressure control during procedures than either drug used individually. ## Clinical Applications The primary use of this combination is in anesthesia and critical care settings, particularly: - **Perioperative blood pressure management**: Studies have shown that the combination of nicardipine and esmolol is more effective at blunting the peak increase in blood pressure after laryngoscopy and tracheal intubation compared to either drug alone. - **Acute aortic dissection management**: The combination can be used as part of initial medical management for aortic dissection, with esmolol controlling heart rate and nicardipine reducing blood pressure. ## Efficacy and Safety Research has demonstrated that when used in combination (even at half doses of each drug), nicardipine and esmolol provide superior blood pressure control compared to full doses of either medication alone. However, it's worth noting that neither the combination nor the individual drugs were completely effective at preventing increases in heart rate during procedures in some studies. Both drugs can have additive effects in lowering blood pressure and heart rate, which may cause side effects such as headache, dizziness, and lightheadedness. Careful monitoring is required when administering this combination. ## Hemodynamic Effects The combination affects various cardiac parameters: - Reduces blood pressure and rate-pressure load - Esmolol can increase minimal lumen diameter - Nicardipine may be associated with negative remodeling of distal segments For specific clinical scenarios like postcraniotomy emergence hypertension, nicardipine has been found to be more effective as a sole agent than esmolol, though the combination provides complementary benefits in many situations.

02

Targets

CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)ADRB1 (β1)

Beyond the preview

Go deeper on Nicardipine and Esmolol combination.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicardipine and Esmolol combination.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call